Fuchs Henry J's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed Mar 7, 2024
- Accession no.
- 0001048477-24-000034
- Filed
- Mar 7, 2024
- Trade date
- Mar 5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $3.01M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fuchs Henry JCIK 0001197355 | Officer (President, Worldwide R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | Common Stock | SSaleDisposed | −35,341 | $85.18 | −$3,010,346.38 | 212,117 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.